These success, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the concept of focusing on ACKR3 as a singular way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-associated Diseases. At that point, Microsoft Marketing https://frankw949clr5.wikifrontier.com/user